Entrada Therapeutics
TRDA
TRDA
33 hedge funds and large institutions have $386M invested in Entrada Therapeutics in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
13% less funds holding
Funds holding: 38 → 33 (-5)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Holders
33
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$8.42M | |
| 2 | +$1.99M | |
| 3 | +$1.7M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$1.5M |
| 5 |
BlackRock
New York
|
+$1.3M |
Top Sellers
| 1 | -$8.33M | |
| 2 | -$6.95M | |
| 3 | -$1.99M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
-$1.29M |
| 5 |
Millennium Management
New York
|
-$932K |